COMMUNITY HEALTH SYSTEMS INC (CYH)
Sector: Health Care
2026 Annual Meeting Analysis
COMMUNITY HEALTH SYSTEMS INC · Meeting: May 12, 2026
Directors FOR
14
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Directors
Director since 2022 (within 24-month exemption window for TSR trigger); relevant healthcare and regulatory experience; no overboarding or attendance concerns identified.
Director since 2023 (within 24-month exemption window for TSR trigger); cybersecurity and national security expertise relevant to the company's risk oversight needs; no other disqualifying flags.
Long-tenured director (since 2003) with extensive CFO and executive leadership experience; CYH's 3-year price return is -37.3% versus IHF's -13.3%, a gap of -24.0pp, which does not meet the 30pp threshold required to trigger an AGAINST vote given the negative absolute TSR tier, so the TSR trigger does not fire; no overboarding concerns (one public board seat disclosed).
Director since 2017 with strong CFO and financial oversight credentials; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); serves on two other public boards (Aebi Schmidt, Crane NXT), within policy limits.
Director since 2009 with deep healthcare finance expertise; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); serves on one other public board (Select Medical), no overboarding concern.
Director since 2004 with relevant financial management and academic healthcare system experience; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
CEO and Director since 2025 (within 24-month exemption window for TSR trigger as a director); nearly three decades of financial and operational leadership at the company provides strong relevant expertise.
Director since 2021 with healthcare practitioner perspective and prior public company board experience; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
Director since 2018 with strong accounting, SEC reporting, and finance executive background; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
Director since 2008 with 40+ years of physician and healthcare practice management experience; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
Director since 2017 with academic medical center executive leadership and healthcare regulatory expertise; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
Director since 2024 (within 24-month exemption window for TSR trigger); deep healthcare industry media and governance expertise; no overboarding or attendance concerns identified.
Chairman since 1997 with unparalleled healthcare industry tenure as former CEO; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold for the negative absolute TSR tier); no overboarding concerns and proxy discloses approximately 99% board attendance in 2025.
Director since 2015 with accounting doctorate, legal credentials, and audit expertise; TSR trigger does not fire (gap of -24.0pp versus IHF is below the 30pp threshold); no overboarding or attendance concerns identified.
All 14 director nominees receive a FOR vote. CYH's 3-year price return of -37.3% trails the IHF benchmark by -24.0 percentage points, which falls below the 30pp threshold required to trigger AGAINST votes under the negative absolute TSR tier. Five directors joined within the past 24 months (Brooks 2022, Burgess 2023, Hammons 2025, Lopez 2024) and are exempt from the TSR trigger in any event. The board is well-structured with strong independence, relevant healthcare and financial expertise, a skills matrix disclosed, audit committee financial experts identified, and approximately 99% meeting attendance reported for 2025.
Say on Pay
✓ FORCEO
Kevin J. Hammons
Total Comp
$4,772,869
Prior Support
97%%
The prior Say on Pay vote received approximately 97% support at the 2025 annual meeting, well above the 70% threshold that would require a response check. CEO Kevin Hammons received total compensation of approximately $4.8 million for his partial year as CEO (he became interim CEO in October 2025 and permanent CEO in December 2025), which is reasonable relative to benchmarks for a small-cap ($410M market cap) healthcare provider CEO. The pay program structure is sound: 75% of long-term incentive awards are performance-based (tied to multi-year financial goals and stock price), the company discloses a clawback policy broader than NYSE requirements, and incentive payouts for 2025 reflect above-threshold but capped performance, which is consistent with actual company results showing positive free cash flow and same-store revenue growth of 4.6%.
Auditor Ratification
✓ FORAuditor
Deloitte & Touche LLP
Tenure
N/A
Audit Fees
N/A
Non-Audit Fees
N/A
Deloitte & Touche LLP is a Big 4 firm appropriate for a company of CYH's size and complexity. Auditor tenure is not explicitly disclosed in the portions of the proxy provided, so the tenure trigger cannot fire per policy (vote FOR when tenure is undisclosed). No fee table data was included in the provided filing text, so the non-audit fee ratio trigger cannot be evaluated, and the default FOR applies. No material restatements are disclosed.
Overall Assessment
The 2026 Community Health Systems annual meeting presents a clean ballot with three standard proposals — director elections, Say on Pay, and auditor ratification — all receiving FOR votes. The board's stock performance relative to the IHF benchmark falls just short of the AGAINST trigger threshold (-24.0pp gap versus the 30pp required), the pay program is well-structured with strong shareholder support, and Deloitte is an appropriate Big 4 auditor for the company.
Compensation Peer Group
1 companies disclosed in 2026 proxy filing